What Is The Press Saying About Us

Explore the diverse perspectives and insightful coverage from Aesthetic Connection and its suppliers. This area is dedicated to sharing a variety of press mentions and media features that provide a well-rounded view of our company and its endeavours. It’s a space where you can access articles, reviews, and reports from respected journalists and media outlets, offering an objective look at what we do and how we’re perceived in the industry.

Resteeme

Assessing the efficacy and safety of injectable non-cross-linked hyaluronic acid for facial skin rejuvenation.

Resteeme

Comparing hyaluronic acid-based formulations and their effects on cellular repair mechanisms in human keratinocytes.

Prollenium®

Recognising Prollenium® for industry leadership and excellence at Aesthetic Next 2025.

Retix.C

Evaluating the effects of SMART DNA Therapy Retix.C on the skin microbiome and microbial balance.

Prollenium®

Expanding the Revanesse® portfolio with Renew™+, a skin booster developed to support skin quality and rejuvenation.

Resteeme

Investigating the anti-glycation effects of injectable hyaluronic acid and trehalose formulations in human skin tissue.

Resteeme

Examining the synergistic role of hyaluronic acid and trehalose in mitigating glycation and oxidative stress in skin ageing.

SoftFil®

A practical clinical guide to micro-cannula injection techniques for enhanced precision, safety and control in aesthetic procedures.

Resteeme

Evaluating the corrective anti-glycation potential of dual-weight hyaluronic acid and trehalose in human skin tissue.

MCCM

MCCM Medical Cosmetics showcased its latest developments in aesthetic medicine at AMWC Monaco 2023.

Prollenium®

TOPILASE® - A topical issue

Prollenium®

Prollenium® announcing it's acquisition of SoftFil, pushing the boundaries for precise and safe results.

Revanesse®

Revanesse® making waves in the UK for its spherical shape - Case study available in UK magazine - Aesthetic Medicine.